capopedia
    • Largest by market cap
      Trillion-dollar club — companies by total market valuation
    • Highest revenue
      Revenue giants — ranked by total annual sales
    • Biggest employers
      Job creators — ranked by total global headcount
    Search...
    Sign in Sign up
    capopedia
    Search...
    capopedia
      • Largest by market cap
        Trillion-dollar club — companies by total market valuation
      • Highest revenue
        Revenue giants — ranked by total annual sales
      • Biggest employers
        Job creators — ranked by total global headcount
    Sign in Sign up

    Gilead Sciences, Inc (FY2025) Dossier

    Public Dossier • Editorial
    Unofficial • Transformative Not affiliated with or endorsed by the subject or rights holders. AI chat draws on public facts for transformative, educational use.
    A biopharmaceutical leader leveraging its market dominance in HIV treatment and prevention to fuel strategic expansion into oncology. Growth is propelled by its durable virology franchise and an advancing oncology portfolio, supported by pipeline innovation like the new twice-yearly HIV prevention drug and targeted acquisitions, underscoring its long-term investment relevance.
    Chat · Research with this Dossier
    Follow this Dossier
    • Overview
    • Insights

    Loading Gilead Sciences, Inc's insights. Please wait.

    Contact us at [email protected]
    Copyright © 2026 capopedia. All rights reserved.